The Chemours Co (NYSE:CC)
$ 18.89 -0.53 (-2.73%) Market Cap: 2.90 Bil Enterprise Value: 6.86 Bil PE Ratio: 39.63 PB Ratio: 4.41 GF Score: 72/100

Q4 2019 Chemours Co Earnings Call Transcript

Feb 14, 2020 / 01:30PM GMT
Release Date Price: $19.37 (+23.53%)
Operator

Ladies and gentlemen, thank you for standing by. And welcome to The Chemours Company Fourth Quarter 2019 Earnings Conference Call.

(Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to Jonathan Lock, Vice President of Corporate Development and Investor Relations. Thank you.

Please go ahead, sir.

Jonathan Lock
The Chemours Company - VP of Corporate Development & IR

Good morning. And welcome to The Chemours Company's Full Year 2019 Earnings Conference Call.

I'm joined today by Mark Vergnano, President and Chief Executive Officer; Mark Newman, Senior Vice President and Chief Operating Officer; and Sameer Ralhan, Senior Vice President and Chief Financial Officer.

Before we start, I'd like to remind you that comments made on this call as well as the supplemental information provided in our presentation and on our website contain forward-looking statements that involve risks and uncertainties, including those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot